This report contains market size and forecasts of Retinal Dystrophy Treatment in Global, including the following market information:
Global Retinal Dystrophy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Retinal Dystrophy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gene Therapy Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Retinal Dystrophy Treatment include Spark Therapeutics (Roche), Novartis AG, GlaxoSmithKline, Applied Genetic Technologies Corporation, Oxford BioMedica, Biogen, HORAMA S.A., MeiraGTx Limited and Novelion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinal Dystrophy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Dystrophy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Retinal Dystrophy Treatment Market Segment Percentages, by Type, 2021 (%)
Gene Therapy Treatment
Symptomatic Treatment
Global Retinal Dystrophy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Retinal Dystrophy Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Retinal Dystrophy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Retinal Dystrophy Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Dystrophy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Retinal Dystrophy Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Spark Therapeutics (Roche)
Novartis AG
GlaxoSmithKline
Applied Genetic Technologies Corporation
Oxford BioMedica
Biogen
HORAMA S.A.
MeiraGTx Limited
Novelion Therapeutics
IVERIC bio
Reflection Biotechnologies